nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.101	0.149	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.101	0.149	CbGbCtD
Cilostazol—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0757	0.112	CbGbCtD
Cilostazol—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0606	0.0893	CbGbCtD
Cilostazol—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0485	0.0714	CbGbCtD
Cilostazol—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0464	0.0683	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0464	0.0683	CbGbCtD
Cilostazol—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0348	0.0512	CbGbCtD
Cilostazol—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0319	0.0469	CbGbCtD
Cilostazol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0318	0.0468	CbGbCtD
Cilostazol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0295	0.0435	CbGbCtD
Cilostazol—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0237	0.0349	CbGbCtD
Cilostazol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0136	0.02	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0133	0.0196	CbGbCtD
Cilostazol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0124	0.0183	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00848	0.0125	CbGbCtD
Cilostazol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000632	CcSEcCtD
Cilostazol—Pain—Vincristine—peripheral nervous system neoplasm	0.000203	0.000631	CcSEcCtD
Cilostazol—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000631	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000631	CcSEcCtD
Cilostazol—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00063	CcSEcCtD
Cilostazol—Rash—Melphalan—peripheral nervous system neoplasm	0.000202	0.000629	CcSEcCtD
Cilostazol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000202	0.000629	CcSEcCtD
Cilostazol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.000627	CcSEcCtD
Cilostazol—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000625	CcSEcCtD
Cilostazol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.0002	0.000624	CcSEcCtD
Cilostazol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000623	CcSEcCtD
Cilostazol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000622	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000199	0.00062	CcSEcCtD
Cilostazol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000198	0.000617	CcSEcCtD
Cilostazol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00061	CcSEcCtD
Cilostazol—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000609	CcSEcCtD
Cilostazol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000609	CcSEcCtD
Cilostazol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000606	CcSEcCtD
Cilostazol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000606	CcSEcCtD
Cilostazol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000194	0.000605	CcSEcCtD
Cilostazol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000194	0.000604	CcSEcCtD
Cilostazol—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000604	CcSEcCtD
Cilostazol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000193	0.000601	CcSEcCtD
Cilostazol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000193	0.000601	CcSEcCtD
Cilostazol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.0006	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000595	CcSEcCtD
Cilostazol—Infection—Etoposide—peripheral nervous system neoplasm	0.000191	0.000594	CcSEcCtD
Cilostazol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000593	CcSEcCtD
Cilostazol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00019	0.000593	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000591	CcSEcCtD
Cilostazol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00059	CcSEcCtD
Cilostazol—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00059	CcSEcCtD
Cilostazol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000586	CcSEcCtD
Cilostazol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000188	0.000586	CcSEcCtD
Cilostazol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000187	0.000584	CcSEcCtD
Cilostazol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000187	0.000584	CcSEcCtD
Cilostazol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000187	0.000584	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000583	CcSEcCtD
Cilostazol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000582	CcSEcCtD
Cilostazol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000187	0.000581	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000579	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000577	CcSEcCtD
Cilostazol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000574	CcSEcCtD
Cilostazol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000183	0.00057	CcSEcCtD
Cilostazol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000568	CcSEcCtD
Cilostazol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000567	CcSEcCtD
Cilostazol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000182	0.000566	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000564	CcSEcCtD
Cilostazol—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00056	CcSEcCtD
Cilostazol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000179	0.000559	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000559	CcSEcCtD
Cilostazol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000558	CcSEcCtD
Cilostazol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.00055	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000546	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000546	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000545	CcSEcCtD
Cilostazol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000542	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000538	CcSEcCtD
Cilostazol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000172	0.000537	CcSEcCtD
Cilostazol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000171	0.000533	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000531	CcSEcCtD
Cilostazol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00017	0.00053	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000529	CcSEcCtD
Cilostazol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000169	0.000526	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000525	CcSEcCtD
Cilostazol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.000524	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000521	CcSEcCtD
Cilostazol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.000521	CcSEcCtD
Cilostazol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000167	0.00052	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000518	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000166	0.000516	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000516	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000512	CcSEcCtD
Cilostazol—Pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.000512	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000511	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000511	CcSEcCtD
Cilostazol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000507	CcSEcCtD
Cilostazol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000162	0.000505	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000504	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000501	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000497	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000496	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000493	CcSEcCtD
Cilostazol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000158	0.000493	CcSEcCtD
Cilostazol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.000491	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000491	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000489	CcSEcCtD
Cilostazol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000157	0.000489	CcSEcCtD
Cilostazol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000157	0.000488	CcSEcCtD
Cilostazol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.000487	CcSEcCtD
Cilostazol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000483	CcSEcCtD
Cilostazol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000483	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000482	CcSEcCtD
Cilostazol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.00048	CcSEcCtD
Cilostazol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000153	0.000475	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000474	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000473	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000152	0.000473	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000152	0.000473	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000473	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000473	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000472	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00047	CcSEcCtD
Cilostazol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000151	0.00047	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000468	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000468	CcSEcCtD
Cilostazol—Rash—Vincristine—peripheral nervous system neoplasm	0.000149	0.000466	CcSEcCtD
Cilostazol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000149	0.000465	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000465	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000464	CcSEcCtD
Cilostazol—Headache—Vincristine—peripheral nervous system neoplasm	0.000149	0.000463	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00046	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000459	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000456	CcSEcCtD
Cilostazol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000455	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000454	CcSEcCtD
Cilostazol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000447	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000446	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00044	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000439	CcSEcCtD
Cilostazol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000141	0.000439	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000438	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000438	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000437	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000435	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000433	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00043	CcSEcCtD
Cilostazol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000138	0.000429	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000428	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000425	CcSEcCtD
Cilostazol—Chills—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000423	CcSEcCtD
Cilostazol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000136	0.000423	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000133	0.000415	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000413	CcSEcCtD
Cilostazol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000412	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000411	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000131	0.000409	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000407	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000405	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000405	CcSEcCtD
Cilostazol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000397	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000396	CcSEcCtD
Cilostazol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000127	0.000396	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000395	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000394	CcSEcCtD
Cilostazol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000392	CcSEcCtD
Cilostazol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000388	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000381	CcSEcCtD
Cilostazol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000122	0.00038	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00038	CcSEcCtD
Cilostazol—Rash—Etoposide—peripheral nervous system neoplasm	0.000121	0.000377	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000121	0.000377	CcSEcCtD
Cilostazol—Headache—Etoposide—peripheral nervous system neoplasm	0.00012	0.000375	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000375	CcSEcCtD
Cilostazol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000371	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000369	CcSEcCtD
Cilostazol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000368	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000368	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000368	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000365	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000363	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000361	CcSEcCtD
Cilostazol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000359	CcSEcCtD
Cilostazol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000114	0.000355	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000355	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000353	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000351	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00035	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00035	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00035	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000349	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000347	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000346	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000343	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000342	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000341	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00034	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000336	CcSEcCtD
Cilostazol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000335	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000334	CcSEcCtD
Cilostazol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000333	CcSEcCtD
Cilostazol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000332	CcSEcCtD
Cilostazol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00033	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000329	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000328	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000328	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000327	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000326	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000324	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000324	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000324	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000323	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000321	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00032	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00032	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000313	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.00031	CcSEcCtD
Cilostazol—Infection—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000308	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000305	CcSEcCtD
Cilostazol—Shock—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000305	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000304	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000304	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000303	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000303	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000301	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000301	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000299	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000296	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000295	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.000291	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.00029	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000289	CcSEcCtD
Cilostazol—Pain—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000287	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000283	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000281	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000279	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000277	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000276	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000274	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000273	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.00027	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000268	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.55e-05	0.000266	CcSEcCtD
Cilostazol—Pain—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000265	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000265	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000265	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000256	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000254	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000246	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000245	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000245	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000241	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000237	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000229	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000223	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000222	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.00022	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000213	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000212	CcSEcCtD
Cilostazol—Rash—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000211	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.78e-05	0.000211	CcSEcCtD
Cilostazol—Headache—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.00021	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000205	CcSEcCtD
Cilostazol—Nausea—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000199	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000197	CcSEcCtD
Cilostazol—Rash—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000196	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000195	CcSEcCtD
Cilostazol—Headache—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000194	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000184	CcSEcCtD
